Intelligent Bio Solutions Inc. (INBS) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the Intelligent Buyer Solutions, Inc. First Quarter 2023 Earnings Conference Call. Currently, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference call is being recorded. Joining us on the call today from the company are Harry Assuminaitis, CEO and Chairman of the Board, Spiros Akiris, Chief Financial Officer, and Philip Hand, Executive Chairman of Intelligent Fingerprinting Limited. A press release announcing the results and the update has been issued this afternoon and is available now on the company's website. If you haven't received this news release or if you'd like to be added to the company's distribution list, please contact the Investor Relations Department noted at the bottom of the earnings release. Some of the statements on this conference call for forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1985, which involves risks and uncertainties. Forward-looking statements on this call include, without limitation, Intelligent Biosolutions, Inc.' 's ability to develop and commercialize its diagnostic tests, realize commercial benefits from its partnership and collaborations, and secure regulatory approvals, among others. Although Intelligent Biosolutions, Inc. believes these expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove the results have been materially different from the results expressed or implied by such forward-looking statements. Intelligence Biosolutions, Inc. has attempted to identify forward-looking statements by terminology inc...